Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA “Failure” To Approve Generic Biologics Questioned By Commerce Cmte.

Feb 05 2007

• By Daniel Poppy

Related Content

Biogenerics Bill Differs From ANDA System In Exclusivity, Patent Listing

Oct 09 2006

Governors Take Aim At FDA For Not Releasing Follow-On Biologics Guidances

Aug 14 2006

Follow-On Biologics Could Save Medicare $14 Bil. Over 10 Years – PCMA

Jan 08 2007

BIO CEO Greenwood In A Conversation With “The Pink Sheet”

Jan 15 2007

FDA Faces Pricing Pressure As Generic Drug User Fee Debate Begins

Feb 27 2006

FDA To See Increased Funding, Oversight From Approps Committees In 2007

Nov 27 2006

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window